48 related articles for article (PubMed ID: 11328295)
1. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
Komada Y; Zhang SL; Zhou YW; Hanada M; Shibata T; Azuma E; Sakurai M
Cancer Immunol Immunother; 1992; 35(4):271-6. PubMed ID: 1511462
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.
Peragine N; Torelli GF; Mariglia P; Pauselli S; Vitale A; Guarini A; Foà R
Cancer Immunol Immunother; 2015 Feb; 64(2):201-11. PubMed ID: 25341808
[TBL] [Abstract][Full Text] [Related]
3. Granular acute lymphoblastic leukemia in a 15-year-old boy.
Cap J; Babusikova O; Kaiserova E; Panzer-Grünmayer R
Med Oncol; 2000 May; 17(2):144-6. PubMed ID: 10871821
[TBL] [Abstract][Full Text] [Related]
4. Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
Duault C; Kumar A; Taghi Khani A; Lee SJ; Yang L; Huang M; Hurtz C; Manning B; Ghoda L; McDonald T; Lacayo NJ; Sakamoto KM; Carroll M; Tasian SK; Marcucci G; Yu J; Caligiuri MA; Maecker HT; Swaminathan S
Blood; 2021 Oct; 138(16):1465-1480. PubMed ID: 34077953
[TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells (CLPD-NK): a case report and literature review.
An H; Guo J; Guo H; Hu W; Lu M
BMC Neurol; 2023 Sep; 23(1):314. PubMed ID: 37658347
[TBL] [Abstract][Full Text] [Related]
6. Intravascular NK/T-cell lymphoma: a series of four cases.
Yan J; Zhang F; Luo D; Yao S; Chen Y; Xu F; Luo X; He J; Liu Y
Int J Clin Exp Pathol; 2017; 10(9):9541-9550. PubMed ID: 31966830
[TBL] [Abstract][Full Text] [Related]
7. A case of excisionally remitted indolent NK-cell enteropathy in the oral cavity and a mini-review.
Li X; Li Z; Zhou X; Zheng Y; Zhang Y; Xie J
J Cutan Pathol; 2024 Jul; 51(7):518-524. PubMed ID: 38642003
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of smouldering Human T cell Leukemia Virus Type1 associated bronchiolitis and alveolar abnormalities with amplified natural killer therapy.
Nagai K; Nagai S; Hara Y
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34876443
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection.
Chowdhury UN; Faruqe MO; Mehedy M; Ahmad S; Islam MB; Shoombuatong W; Azad AKM; Moni MA
Comput Biol Med; 2021 Nov; 138():104891. PubMed ID: 34624759
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma.
Kim Y; Kang MS; Kim CW; Sung R; Ko YH
J Korean Med Sci; 2005 Apr; 20(2):319-24. PubMed ID: 15832009
[TBL] [Abstract][Full Text] [Related]
11. What is CD4+CD56+ malignancy and how should it be treated?
Reimer P; Rüdiger T; Kraemer D; Kunzmann V; Weissinger F; Zettl A; Konrad Müller-Hermelink H; Wilhelm M
Bone Marrow Transplant; 2003 Oct; 32(7):637-46. PubMed ID: 13130309
[TBL] [Abstract][Full Text] [Related]
12. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
14. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
15. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
[TBL] [Abstract][Full Text] [Related]
16. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
17. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
